{"product_id":"lamtor3-antibody-sc-f1438","title":"LAMTOR3\/MAPKSP1 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eLAMTOR3 (late endosomal\/lysosomal adaptor and MAPK and MTOR activator 3), also known as MAPKSP1, is a roadblock domain-only subunit involved in tumorigenesis and development. It acts as a scaffold protein complex in the nucleus during anaphase mitosis and plays a critical role in various cancers by interacting with MAPK1\/ERK2, a polymeric mitogen-activated protein kinase. Depending on the literature source, LAMTOR3 may also be discussed as LAMTOR3\/MAPKSP1.\u003c\/p\u003e\u003cp\u003eReported cellular context includes endosome and membrane, which can matter when signal is compared across treatments or changing cell states. Following LAMTOR3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eLAMTOR3 is commonly interpreted in the context of cancer, apoptosis, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans endosome and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between endosome and membrane across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003eseparation of survival-associated changes from stress or death-associated readouts\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for LAMTOR3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in LAMTOR3 reflect biology rather than handling. When interpreting LAMTOR3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep LAMTOR3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577744630105,"sku":"F1438-20UL","price":149.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577744662873,"sku":"F1438-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577744695641,"sku":"F1438-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F1438-IHC1.jpg?v=1773599750","url":"https:\/\/absource.de\/products\/lamtor3-antibody-sc-f1438","provider":"Absource Diagnostics","version":"1.0","type":"link"}